A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

ABSTRACT:

SUBMITTER: Strati P 

PROVIDER: S-EPMC6119133 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature